
Callosum
Cambridge AI startup; first equity investment from the UK Sovereign AI Unit, named 16 April 2026.
Callosum, a Cambridge chip-interoperability start-up, became the UK Sovereign AI Unit's first direct equity investment when DSIT named its inaugural cohort on 16 April 2026; four more stakes have followed since.
Last refreshed: 4 August 2026 · Appears in 2 active topics
Why did the UK Sovereign AI Unit hand Callosum the only equity cheque in its first cohort?
Timeline for Callosum
Mentioned in: UK weekly tech funding falls 72%
UK Startups and InnovationRaised a $100m seed round
UK Startups and Innovation: Cambridge brain duo raise $100m seedMentioned in: Britain buys into a chip startup
European Tech SovereigntyMentioned in: State fund surfaces on CuspAI cap table
UK Startups and InnovationMentioned in: UK launches £96m Sovereign AI wave
European Tech SovereigntyBackground
Callosum was founded by Cambridge PhD graduates Danyal Akarca and Jascha Achterberg to build chip-optimisation software that lets heterogeneous silicon fleets, mixing Nvidia, AMD, Intel and emerging European hardware, interoperate rather than lock workloads to a single vendor's architecture.
The interoperability problem it addresses is structural to European AI sovereignty: without software abstracting across chip architectures, European data centres and research facilities remain tied to individual hardware vendors, reproducing the very lock-in that sovereign cloud and compute policy is meant to eliminate.
If other Sovereign AI Unit investees are building applications, Callosum is building the plumbing beneath them that lets those applications run on non-US silicon, a positioning distinct from the model-training and inference-chip companies elsewhere in the unit's portfolio.
Callosum stood out from a compute-only cohort
When the Sovereign AI Unit named its first cohort of seven firms on 16 April 2026, Callosum was the only one to receive a direct equity stake; the other six, including Cosine and Odyssey, received compute access via the AI Research Resource instead. That distinction marked Callosum as the programme's highest-confidence bet among an otherwise compute-only cohort.
Four more direct stakes have followed since, in Ineffable Intelligence, Isomorphic Labs, CuspAI and Olix, but Callosum remains the only one drawn from the original seven-firm cohort rather than a later deal.